- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Atherosclerotic cardiovascular disease with elevated triglycerides
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 562KB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 100KB)
Icosapent ethyl – March 2024
Icosapent Ethyl: Capsule 1 g; Vazkepa®
Last updated
30 May 2025